Navigation auf zora.uzh.ch

Search ZORA

ZORA (Zurich Open Repository and Archive)

Agomelatine for depression in schizophrenia: A case-series

Mutschler, Jochen; Rüsch, Nicolas; Schönfelder, Herdis; Herwig, Uwe; Brühl, Annette Beatrix; Grosshans, Martin; Rössler, Wulf; Russmann, Heike (2012). Agomelatine for depression in schizophrenia: A case-series. Psychopharmacology Bulletin, 45(1):35-43.

Abstract

OBJECTIVES: Agomelatine, a melatonin (MT1/MT2) receptor agonist and 5-HT2C receptor antagonist, is a new antidepressant and a potential therapeutic option for major depressive episodes and negative symptoms in persons with schizophrenia. We investigated such treatment outcomes with respect to antidepressant efficacy, safety, and tolerability.
METHODS: We report a consecutive case series of seven patients with schizophrenia and comorbid major depressive symptoms who received agomelatine for a period of at least six weeks in addition to stable doses of antipsychotic agents. General psychopathology, positive, negative and depressive symptoms were assessed with standardized interviews. Relevant blood parameters were assessed.
RESULTS: Depressive symptoms improved significantly. Positive symptoms remained stable, while negative symptoms and global psychopathology improved significantly. Agomelatine was well tolerated in most patients.
CONCLUSIONS: Our findings provide initial evidence that agomelatine is safe and efficacious in treating depressive symptoms in patients with schizophrenia. Furthermore, agomelatine seems to be effective for the treatment of negative symptoms. Randomized controlled trials are necessary to confirm these first observations.

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Psychiatric University Hospital Zurich > Clinic for Clinical and Social Psychiatry Zurich West (former)
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Psychiatry and Mental Health
Health Sciences > Pharmacology (medical)
Language:English
Date:2012
Deposited On:13 Feb 2013 13:55
Last Modified:24 Oct 2024 03:39
Publisher:MedWorks Media Global
ISSN:0048-5764
OA Status:Green
Free access at:PubMed ID. An embargo period may apply.
Related URLs:http://www.medworksmedia.com/
PubMed ID:27738367
Download PDF  'Agomelatine for depression in schizophrenia: A case-series'.
Preview
  • Content: Published Version

Metadata Export

Statistics

Citations

Dimensions.ai Metrics
2 citations in Web of Science®
4 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

91 downloads since deposited on 13 Feb 2013
14 downloads since 12 months
Detailed statistics

Authors, Affiliations, Collaborations

Similar Publications